RYVIX | VENAX | RYVIX / VENAX | |
Total Expense Ratio | 1.38 | 0.09 | 1,533% |
Annual Report Gross Expense Ratio | 1.43 | 0.09 | 1,589% |
Fund Existence | 27 years | 21 years | - |
Gain YTD | -10.603 | 1.615 | -656% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 100000 | 3% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.29M | 9B | 0% |
Annual Yield % from dividends | 0.00 | 3.07 | - |
Returns for 1 year | -10.99 | 1.45 | -760% |
Returns for 3 years | 5.79 | 10.46 | 55% |
Returns for 5 years | 79.44 | 164.09 | 48% |
Returns for 10 years | -57.72 | 35.49 | -163% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RAPRX | 11.09 | 0.04 | +0.36% |
Cohen & Steers Real Assets R | |||
RWMFX | 66.07 | 0.15 | +0.23% |
American Funds Washington Mutual R5 | |||
BSGIX | 16.19 | 0.02 | +0.12% |
Baird Small/Mid Cap Growth Institutional | |||
ADCVX | 23.60 | 0.01 | +0.04% |
American Century Disciplined Growth A | |||
FUMIX | 19.12 | -0.06 | -0.31% |
Fidelity SAI US Momentum Index |